Category: News Post
Posted: May 12 2020
Author: CDPE

Results from Samples Checked by Toronto’s Drug Checking Service: April 25 – May 8, 2020

Toronto’s drug checking service offers people who use drugs timely and comprehensive information on the composition of their drugs using the most sophisticated lab-based technologies.  Sign up to receive combined data from samples checked every other week.

 

Checked Samples by Sample Type

Between April 25 – May 8, 2020, 30 samples were checked: 37% (11) were substances and 63% (19) were post-use paraphernalia.

 

Checked Samples by Expected Drug

When a client submits a sample to be checked, they indicate which drug they expect that sample to contain. Of the 30 samples checked between April 25 – May 8, 2020:

  • 19 were expected to be fentanyl
  • 2 were expected to be methamphetamine
  • 3 were expected to be other drugs: cocaine, crack, and ketamine
  • 6 did not have a stated expected drug

 

Expected Fentanyl Samples

Of the 30 samples checked between April 25 – May 8, 2020, 63% (19) were expected to be fentanyl (16% were substances and 84% were post-use paraphernalia).

 

Presence of fentanyl in expected fentanyl samples (19):

  • 11% (2) contained no fentanyl
  • 89% (17) contained fentanyl and other drugs

 

Expected fentanyl samples containing fentanyl and other drugs (17)

Of the 19 samples expected to be fentanyl, 89% (17) contained fentanyl and other drugs. Other drugs found included:

  • 100% (17) of expected fentanyl samples contained caffeine
  • 59% (10) of expected fentanyl samples contained despropionyl fentanyl (4-ANPP)*
  • 41% (7) of expected fentanyl samples contained one or more benzodiazepine or benzodiazepine-related drug*
    • 41% (7) of expected fentanyl samples contained etizolam*
    • 12% (2) of expected fentanyl samples contained flualprazolam*
    • 6% (1) of expected fentanyl samples contained alprazolam (Xanax)*
  • 12% (2) of expected fentanyl samples contained norfentanyl*

 

Other Expected Drug Samples Containing Unexpected Noteworthy Drugs

Of the remaining 11 samples checked between April 25 – May 8, 2020, meaning samples that were not expected to be fentanyl, 27% (3) contained one or more unexpected noteworthy drug. Unexpected noteworthy drugs found included:

  • 33% (2) of samples that did not have a stated expected drug contained phenacetin*
  • 17% (1) of samples that did not have a stated expected drug contained despropionyl fentanyl (4-ANPP)*
  • 17% (1) of samples that did not have a stated expected drug contained fentanyl*
  • 17% (1) of samples that did not have a stated expected drug contained levamisole*

 

*Unexpected noteworthy drug: “Noteworthy drugs” are drugs that are highly potent, linked to overdose or other adverse effects, or may not be desired by some clients. Noteworthy drugs are called out when they are unexpectedly found in checked samples.